Presentation TCT 2016 Complications 3. The Spectrum of Neurologic Events After TAVR: Insights From NeuroARC Presenter: Alexandra J. Lansky October 31, 2016
Presentation TCT 2016 Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR Presenter: Marina Urena October 31, 2016
Presentation TCT 2016 A Practical Algorithm for Managing Para-Valvular Regurgitation After TAVR Presenter: Scott Lim October 31, 2016
Presentation TCT 2016 Updates on New Adjunctive Pharmacotherapy Clinical Trials for TAVR Presenter: Davide Capodanno October 31, 2016
Presentation TCT 2016 Flash Debate: Counterpoint In Lower Risk Patients, A Thoughtful Hybrid Strategy Is Preferred! Presenter: Stephen J.D. Brecker October 31, 2016
Presentation TCT 2016 Flash Debate: Point In Lower Risk Patients, the Minimalist Strategy Should Be the Default Approach! Presenter: Antonio Colombo October 31, 2016
Presentation TCT 2016 Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data Presenter: Ganesh Manoharan October 31, 2016
Presentation TCT 2016 Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience Presenter: John G. Webb October 31, 2016
Presentation TCT 2016 Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience Presenter: Helene Eltchaninoff October 31, 2016
Presentation TCT 2016 Flash Debate: Counterpoint 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy! Presenter: Raj Makkar October 31, 2016